Victory Capital Management Inc. cut its position in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 95.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 38,297 shares of the health services provider's stock after selling 884,315 shares during the quarter. Victory Capital Management Inc. owned approximately 0.07% of Maximus worth $2,859,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Charles Schwab Investment Management Inc. boosted its holdings in Maximus by 7.7% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,000,664 shares of the health services provider's stock worth $74,700,000 after purchasing an additional 71,598 shares during the last quarter. QRG Capital Management Inc. boosted its stake in Maximus by 15.2% in the fourth quarter. QRG Capital Management Inc. now owns 4,993 shares of the health services provider's stock valued at $373,000 after acquiring an additional 657 shares during the last quarter. Versor Investments LP boosted its stake in Maximus by 12.9% in the fourth quarter. Versor Investments LP now owns 9,600 shares of the health services provider's stock valued at $717,000 after acquiring an additional 1,100 shares during the last quarter. Bryn Mawr Capital Management LLC boosted its stake in Maximus by 129.8% in the fourth quarter. Bryn Mawr Capital Management LLC now owns 4,946 shares of the health services provider's stock valued at $369,000 after acquiring an additional 2,794 shares during the last quarter. Finally, Illinois Municipal Retirement Fund raised its position in shares of Maximus by 35.4% in the fourth quarter. Illinois Municipal Retirement Fund now owns 25,273 shares of the health services provider's stock valued at $1,887,000 after purchasing an additional 6,606 shares during the period. 97.21% of the stock is currently owned by hedge funds and other institutional investors.
Maximus Price Performance
Shares of NYSE:MMS traded up $0.09 during trading on Tuesday, reaching $68.11. The company had a trading volume of 146,369 shares, compared to its average volume of 480,251. Maximus, Inc. has a 12 month low of $63.77 and a 12 month high of $93.97. The stock has a market capitalization of $3.86 billion, a P/E ratio of 14.68 and a beta of 0.71. The company has a fifty day moving average of $71.83 and a two-hundred day moving average of $79.13. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.82.
Maximus (NYSE:MMS - Get Free Report) last issued its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. Equities research analysts forecast that Maximus, Inc. will post 6.15 earnings per share for the current year.
Maximus Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Saturday, February 15th were paid a dividend of $0.30 per share. The ex-dividend date was Friday, February 14th. This represents a $1.20 dividend on an annualized basis and a yield of 1.76%. Maximus's dividend payout ratio is currently 25.81%.
Analyst Upgrades and Downgrades
Several analysts have recently issued reports on the stock. Raymond James raised shares of Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price target on the stock in a research report on Thursday, January 2nd. StockNews.com lowered shares of Maximus from a "buy" rating to a "hold" rating in a report on Friday, February 14th.
Check Out Our Latest Stock Report on MMS
Insider Buying and Selling at Maximus
In other news, insider Ilene R. Baylinson sold 14,500 shares of the firm's stock in a transaction dated Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total transaction of $988,030.00. Following the sale, the insider now owns 2,512 shares of the company's stock, valued at $171,167.68. This trade represents a 85.23 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 1.60% of the stock is owned by company insiders.
About Maximus
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Featured Stories
Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
